H. Lundbeck A/S

H. Lundbeck A/S logo
🇩🇰Denmark
Ownership
Public, Subsidiary
Established
2000-01-01
Employees
5.6K
Market Cap
-
Website
http://www.lundbeck.com

Sertindole in Asian Patients With Schizophrenia

Phase 3
Completed
Conditions
Interventions
First Posted Date
2009-03-18
Last Posted Date
2013-09-20
Lead Sponsor
H. Lundbeck A/S
Target Recruit Count
394
Registration Number
NCT00864045
Locations
🇨🇳

CN001, Beijing, China

A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease

Phase 4
Completed
Conditions
Interventions
First Posted Date
2009-03-17
Last Posted Date
2012-09-03
Lead Sponsor
H. Lundbeck A/S
Target Recruit Count
277
Registration Number
NCT00862940

Bifeprunox Extension to Extension Study in Patients With Schizophrenia

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2009-03-13
Last Posted Date
2013-09-16
Lead Sponsor
H. Lundbeck A/S
Target Recruit Count
11
Registration Number
NCT00861497
Locations
🇮🇹

IT001, Brescia, Italy

Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2009-03-06
Last Posted Date
2013-12-05
Lead Sponsor
H. Lundbeck A/S
Target Recruit Count
369
Registration Number
NCT00857649
Locations
🇨🇦

CA019, Edmonton, Alberta, Canada

🇨🇦

CA005, Beauport, Quebec, Canada

🇨🇦

CA009, Toronto, Ontario, Canada

and more 20 locations

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2009-03-06
Last Posted Date
2012-08-29
Lead Sponsor
H. Lundbeck A/S
Target Recruit Count
297
Registration Number
NCT00857233
Locations
🇨🇦

CA022, St. John, New Brunswick, Canada

🇨🇦

CA043, Kelowna, British Columbia, Canada

🇨🇦

CA009, Toronto, Ontario, Canada

and more 30 locations

Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use

Phase 3
Completed
Conditions
Interventions
First Posted Date
2009-03-06
Last Posted Date
2011-08-19
Lead Sponsor
H. Lundbeck A/S
Target Recruit Count
9809
Registration Number
NCT00856583

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2009-03-06
Last Posted Date
2017-03-16
Lead Sponsor
H. Lundbeck A/S
Target Recruit Count
270
Registration Number
NCT00856661
Locations
🇺🇸

US077, Lebanon, New Hampshire, United States

🇺🇸

US064, Shreveport, Louisiana, United States

🇺🇸

US063, Fairfield, Connecticut, United States

and more 149 locations

Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies

First Posted Date
2009-03-04
Last Posted Date
2013-09-20
Lead Sponsor
H. Lundbeck A/S
Target Recruit Count
199
Registration Number
NCT00855686
Locations
🇩🇪

DE001, Munich, Germany

Efficacy of Nalmefene in Patients With Alcohol Dependence

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-12-22
Last Posted Date
2013-07-22
Lead Sponsor
H. Lundbeck A/S
Target Recruit Count
678
Registration Number
NCT00812461
Locations
🇫🇷

FR009, Clichy Cedex 92, France

🇪🇸

ES004, Barcelona, Spain

🇪🇸

ES002, Oviedo, Spain

and more 54 locations
© Copyright 2024. All Rights Reserved by MedPath